Tags |
|
|
Links |
|
|
Just Other Articles - SPAM; Is the FTC Lying to the American People Again?
Recently the Department of Justice’s Federal Trade Commission’s Con
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
sumer Portection Division has put forth a bogus report to Congress
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
on their role in the CAN SPAM Act and stated in writing that SPAM h
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
s been reduced? Man in the online E-Commerce Industry believe this
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
to be a complete fabrication, misrepresentation and bold face lie.
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
Further many believe that those who work in the consumer protection
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
division of the Federal Trade Commission cannot tell a lie from the
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
truth as they so often file fake and bogus or doctored complaints
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
in the court of law. I personally can document at least one case, I
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
know of, yet have heard of such abuses in many industries.
One has
One has
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
to ask if the Federal Trade Commission with its half-breed lawyers
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
who were not smart enough or good enough in school to get a privat
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
practice job understand that their ill-gotten gains and budgetary
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
funds need to be returned to the American People and all those invo
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
lved in this report need to lose their jobs and be barred from ever
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
taking another paycheck from our government. Those who are lawyers
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
in this division should lose their law licenses and be de-barred fo
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
r life. We cannot have an agency, which sends out 8,800 press relea
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
es to toot their own horn, every time their incompetence fails the
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
American people and this is my opinion on the matter. Think on that
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/81280/justotherarticles-SPAM-Is-the-FTC-Lying-to-the-American-People-Again.html">SPAM; Is the FTC Lying to the American People Again?</a>
BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/81280/justotherarticles-SPAM-Is-the-FTC-Lying-to-the-American-People-Again.html]SPAM; Is the FTC Lying to the American People Again?[/url]
Related Articles:
Why is it Impossible for YOU to Make Money Online? You Won't Believe This...
You Can Make Your Sales Copy Believable If You Know How To
Tips for Promoting Your RSS Feed
Bookmark it:
|